Evidence map›Paper›PMID 32842595›Full record

ArticlePharmaceutics2020

Water-Soluble Pristine C

Halyna Kuznietsova, Natalia Dziubenko, Tetiana Herheliuk, Yuriy Prylutskyy, Eric Tauscher, Uwe Ritter, Peter Scharff

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Effects of fullerenol CExperimental and therapeutic medicine · 2026
    Article
  2. Article
  3. Influence of CCancers · 2023
    Article
  4. Fullerene CToxicology research · 2023
    Article
  5. Polyhydroxylated Fullerene CJournal of inflammation research · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Halyna KuznietsovaInstitute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine.ORCID 0000-0002-1296-1007
Natalia DziubenkoInstitute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine.
Tetiana HerheliukInstitute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine.
Yuriy PrylutskyyInstitute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Volodymyrska str., 64, 01601 Kyiv, Ukraine.
Eric TauscherInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany.
Uwe RitterInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany.
Peter ScharffInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, Weimarer str. 25, 98693 Ilmenau, Germany.
Taras Shevchenko National University of Kyiv · UATechnische Universität Ilmenau · DE

Funding

Ministry of Education and Science of Ukraine 0118U000244Ministry of Education and Science of Ukraine 0119U100331
6 · The paper itself

Abstract

Excessive production of reactive oxygen species is the main cause of hepatocellular carcinoma (HCC) initiation and progression. Water-soluble pristine C

Indexed as

5-fluorouracilDLS measurementshepatocellular carcinomaHepG2 cellsoxidative stresswater-soluble pristine C60 fullerene

Identifiers

PMID32842595
PMCPMC7559840
OpenAlexW3080362045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.